Johnson & Johnson and Boston Scientific are currently the companies with the largest market shares in the US electrophysiology devices market. Johnson & Johnson has held majority market share for over a decade. From Q4 2024 to present, Boston Scientific’s Farawave pulsed field ablation catheter has maintained its place as the highest revenue product line in the market, despite Johnson & Johnson having the majority market share. In the coming months, Boston Scientific may continue to climb to overtake Johnson & Johnson, or could remain just behind, says GlobalData.
According to GlobalData’s US Healthcare Facility Invoicing Database, the US electrophysiology market generated nearly $2 billion in Q2 2025. Currently, Johnson & Johnson holds approximately 40 per cent market share with Boston Scientific in second place. Since Q1 2024, Johnson & Johnson has seen a decline in its market share, coinciding with a rise in the market share of Boston Scientific. Since the Farawave was approved in 2024, it has achieved more than double the market share that the next-largest product.
Amy Paterson, Medical Data Analyst at GlobalData, comments, “The market has seen fluctuations historically; however, no other product has been able to gain as much market share as the Farawave. Its rapid growth following launch is impressive. It will be interesting to see if this growth will be able to secure highest market share for Boston Scientific.”
Medtronic is also seeing an increase in its market share, coming close to Abbott. If it can maintain this increase and overtake Abbott, the company will be able to secure the third highest market share.
Paterson concludes, “The electrophysiology device market has constantly changed over time but seems to have steadied recently. Across the market, Boston Scientific and Johnson & Johnson have similar average selling prices. To remain competitive, both companies may need to find ways other than pricing to set them apart.”